Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA Class II (moderate risk, special controls required), regulated under 21 CFR §878.4850 (General, Plastic Surgery panel).
FDA MAUDE casebook
openFDA event book Single Use Only Blood Lancet With An Integr… MID-BOOK · MAUDE
#180 of 1000 · 14,104 reports · 1993–2026
- BOOK 14,104 reports
- RANK #180 of 1000
- DEATH 2 death-typed
- INJ 831 injury-typed
- MALF 13,186 malfunction
- SPAN 1993–2026
- PEAK 2012: 1,573
- PHOTO Endoscope
Nearest event-volume peer: Endoscope, Accessories, Narrow Band Spectrum (185 report gap)
Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature sits #180 of 1000 among tracked device types with 14,104 MAUDE reports spanning 1993–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Malfunction reports run above the device-type norm
Single Use Only Blood Lancet With An Integr… carries 93.5% MALFUNCTION-coded reports, 28.7pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
- INJ 5.9% corpus 30.3% · below corpus mean (-24.4 pp)
- MALF 93.5% corpus 64.8% · above corpus mean (+28.7 pp)
Lead product-problem code Retraction Problem is 82% of coded problems · Lead manufacturer ROCHE DIAGNOSTICS accounts for 73% of manufacturer-tagged reports · Top event location U is 26% of location-tagged rows .
Single Use Only Blood Lancet With An Integr… in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Set
Set, I.V. Fluid Transfer
14,331 reports
- Lens
Lens, Multifocal Intraocular
14,298 reports
- Single Use On… (this)
Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature
14,104 reports
- Endoscope
Endoscope, Accessories, Narrow Band Spectrum
13,919 reports
- Oximeter
Oximeter
13,819 reports
- Catheter
Catheter, Steerable
13,804 reports
What this shows Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature carries 14,104 MAUDE reports, ranked #180 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports fell to 47 in 2025, down from an average of 263 in the two years before.
Related Entities for Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature
Top Manufacturers
Event Locations
Nationwide devices with a comparable volume-and-death footprint
Two openFDA-derived peer sets for Single Use Only Blood Lancet With An Integr…: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (14,104 here).
Similar death-typed counts
Nearest other device types by death-typed report count (2 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Single Use Only Blood Lancet With An Integr… are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Single Use Only Blood Lancet With An Integr…; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.